# Soley Therapeutics, Inc. — Form D

Soley Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-22. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-12-22
- Form: D
- Accession: 0001567619-20-021476
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 32
- Date of first sale: 2020-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-384030

## Issuer

- Name: Soley Therapeutics, Inc.
- CIK: 0001830785
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1 Corporate Drive, South San Francisco, CA, 94080
- Phone: (415) 850-9841

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Ken V Alwyn | Director | South San Francisco, CA |
| Kurosh V Ameri | Director | South San Francisco, CA |
| Yerem V Yeghiazarians | Director | South San Francisco, CA |
| Ken V Alwyn | Executive Officer | South San Francisco, CA |

## More

- [CIK 1830785 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1830785&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-20-021476.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.